Sponsor pipeline

Shanghai BDgene Co., Ltd. clinical trial pipeline

Get alerts when Shanghai BDgene Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
2
Phase 2
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06474442 A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex… Herpes Simplex Virus Type I Stromal Keratitis Recruiting 2025-05-18
Phase 1
NCT06465550 A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating… β-thalassemia Recruiting 2024-06-24
NCT06474416 A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex… Herpes Simplex Virus Type I Stromal Keratitis Active, Not Recruiting 2025-05-18
Not applicable
NCT05773729 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat… β-thalassemia Recruiting 2024-06-14
NCT05776173 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat… β-thalassemia Major Recruiting 2024-06-14

Disease areas by active trials

Thalassemia (3)

Get alerts when Shanghai BDgene Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free